Key Highlights
- Titomic (ASX:TTT) shares were down 11.54% at $0.115 during the 22 October 2026 session, against a 0.44% fall in the S&P/ASX 200.
- In its announcement dated 22 October 2026, the company said EXIM approved a USD 10.3 million (AUD 14.7 million) direct Loan to Titomic USA, Inc.
- The loan will fund an integrated high-pressure cold-spray production cell in Huntsville, Alabama, and is expected to support at least dozens of new full-time jobs.
Titomic Limited (ASX:TTT) shares were down 11.54% at $0.115 during the Trading session on 22 October 2026, at the time of the data. By comparison, the S&P/ASX 200 stood at 8,792.20, down 0.44%, and the All Ordinaries stood at 8,916.20, down 0.45%. Titomic is an advanced Manufacturing company that uses its proprietary cold spray Titomic Kinetic Fusion technology and is headquartered in Huntsville, Alabama. In its announcement dated 22 October 2026, the company said the Export-Import Bank of the United States had approved a USD 10.3 million direct loan to its US subsidiary.
About the Company
Titomic Limited is listed on the ASX under the code TTT and describes itself as a global advanced manufacturing company serving the United States and allied industrial base. Its Global Headquarters is in Huntsville, Alabama, with a local presence in Australia and Europe.
The company's chief executive officer and managing director is Jim Simpson, and its chief financial officer is Geoff Hollis. The group's United States operations are conducted through Titomic USA, Inc., the entity named as the borrower in the latest announcement.
Business Overview
Titomic specialises in large integrated solutions for industrial-scale metal additive manufacturing, coating and repairs. These solutions use its patented Titomic Kinetic Fusion cold spray technology, which the company says delivers competitive advantages at every stage of the metal additive manufacturing product value chain.
The company provides original equipment manufacturer production and Research and Development services to the aerospace, defence, shipbuilding, oil and gas, Mining and automotive industries. It also offers global sales and support for its cold spray activities from its Huntsville headquarters.
EXIM Direct Loan Approval
In its announcement dated 22 October 2026, with the dateline of 21 October 2026, Titomic said the Export-Import Bank of the United States, known as EXIM, approved a direct loan of USD 10.3 million, equivalent to AUD 14.7 million, to Titomic USA, Inc. The loan supports the expansion of advanced manufacturing capabilities in Huntsville, Alabama.
The financing is provided under EXIM's Make More in America Initiative, which extends financing to export-oriented domestic manufacturing projects, particularly in sectors critical to national security. The announcement did not state the loan's interest rate, term or repayment schedule.
Production Cell and Job Creation
The funds will be used to purchase an integrated high-pressure cold-spray production cell. According to the company, this will expand its domestic capacity to manufacture, repair and restore high-performance metal components in the United States.
The transaction is expected to support at least dozens of new full-time jobs in Alabama. Comments in the announcement came from EXIM Chairman John Jovanovic, Titomic CEO Jim Simpson and a US congressional representative for Alabama, who each referred to domestic manufacturing capacity, skilled jobs and industrial Supply chains. The project is described as helping reduce reliance on overseas production and supporting export-oriented growth from Huntsville, which the announcement calls a growing hub for aerospace and defence innovation.
Related Sector Context
Advanced manufacturing covers production methods such as metal additive manufacturing, in which components are built, coated or repaired using specialised equipment rather than conventional machining alone. Cold spray processes accelerate metal powders at high speed to form coatings or structures, and are applied in sectors such as aerospace and defence.
Technology and industrial small-cap stocks can trade with different Volatility from the wider market. During the 22 October 2026 session the S&P/ASX 200 was down 0.44% and the All Ordinaries was down 0.45%, compared with the 11.54% fall in Titomic shares at the time of the data.
Risks to Weigh In
The announcement describes an approval of a direct loan but does not set out the conditions, disbursement timetable or repayment terms, so the timing of funds reaching the company is not stated. The production cell has yet to be purchased and installed, and the job creation described is an expectation rather than a reported outcome.
The company's forward-looking statements note that its Business is subject to risks inherent in developing and commercialising technology, some beyond its control, and that actual results could differ materially from those expressed. Demand from the aerospace, defence and other industrial customers it serves also depends on factors outside its control.
Catalysts on Watch
The announcement does not give dates for the production cell purchase or the start of operations. Matters that may be disclosed in future include the financing terms, the delivery and commissioning of the cell, and the hiring in Alabama.
Titomic also invites investors to sign up to its Investor Hub for ASX announcements, video summaries and question-and-answer sessions, which are channels through which further updates may be provided.
Putting It Together
Titomic shares were down 11.54% at $0.115 during the 22 October 2026 session. The announcement of the same date reports an EXIM-approved direct loan of USD 10.3 million to fund a cold-spray production cell in Huntsville, while details of loan conditions and timing were not stated.






Please wait processing your request...